supp.fit

Vitamin B12: study protocols

363 study groups say how much Vitamin B12 participants took a day. These are the doses the studies gave. They are not a recommendation.

Vitamin B12: what the research found →

Dose per serving from products

20,396 products in our catalogue print how much Vitamin B12 a serving holds.

Most common: 5 mcg to 10 mcg, 16% of 20,396 products.

Dose per servingProducts
1 mcg or less
665
1 mcg to 2.5 mcg
3,169
2.5 mcg to 5 mcg
1,806
5 mcg to 10 mcg
3,262
10 mcg to 25 mcg
2,349
25 mcg to 50 mcg
1,591
50 mcg to 100 mcg
1,849
100 mcg to 250 mcg
1,294
250 mcg to 500 mcg
1,295
500 mcg to 1 mg
1,283
1 mg to 2.5 mg
721
2.5 mg to 5 mg
515
over 5 mg
597

Dose per serving from research

363 study groups in 259 studies say how much Vitamin B12 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mcg to 500 mcg, 30% of 363 study groups.

Daily doseStudy groups
1 mcg or less
6
1 mcg to 2.5 mcg
30
2.5 mcg to 5 mcg
25
5 mcg to 10 mcg
28
10 mcg to 25 mcg
9
25 mcg to 50 mcg
15
50 mcg to 100 mcg
10
100 mcg to 250 mcg
7
250 mcg to 500 mcg
108
500 mcg to 1 mg
80
1 mg to 2.5 mg
27
over 2.5 mg
18

Commonly used together

273 of 363 study groups took Vitamin B12 with something else. Shown: what 3 or more different studies gave. The 10 most common of 31.

What was given together, not what works together.

Taken withStudy groups
Folic Acid
211
Vitamin B6
156
Iron
29
Vitamin D
28
Riboflavin
25
Vitamin E
24
Thiamine
23
Zinc
22
Vitamin C
20
Vitamin A
17

363 study groups

Study
Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial
2025 · methylcobalamin group · Women aged 18–75 with HER2-negative early breast cancer receiving adjuvant capecitabine
1.5 mg24 weeks117
Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors
2007 · Homocysteine-lowering group · Myocardial infarction survivors
1 mg6 years—
Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial
2016 · MC group · Men and women aged 18–70 with type 1 or type 2 diabetes and diabetic peripheral neuropathy
1.5 mg24 weeks115
Mecobalamin and early functional outcomes of ischemic stroke patients with H-type hypertension
2018 · observation group · Patients with ischemic stroke and H-type hypertension; age and sex not reported
1.5 mg26 weeks112
Effects of vitamin B-12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial
2015 · Vitamin B-12 · Adults aged 75 years or older with moderate vitamin B-12 deficiency and no anemia
1 mg1 year99
Amelioration by mecobalamin of subclinical carpal tunnel syndrome involving unaffected limbs in stroke patients
2005 · mecobalamin-treated group · Stroke patients; age and sex not reported
1.5 mg2 years67
Efficacy of Danzhixiaoyao tablets combined with methylcobalamin tablets in the treatment of burning mouth syndrome: an open-label, randomized controlled trial
2024 · Control group · Adults aged 18–75 with burning mouth syndrome; gender not limited
1.5 mg4 weeks39
A randomized comparative study of methylcobalamin, methylcobalamin plus pregabalin and methylcobalamin plus duloxetine in patients of painful diabetic neuropathy
2021 · Group B · Adults with type 2 diabetes and painful diabetic neuropathy; age range and sex-specific eligibility not stated
1.5 mg12 weeks34
A randomized comparative study of methylcobalamin, methylcobalamin plus pregabalin and methylcobalamin plus duloxetine in patients of painful diabetic neuropathy
2021 · Group C · Adults with type 2 diabetes and painful diabetic neuropathy; age range and sex-specific eligibility not stated
1.5 mg12 weeks34
A randomized comparative study of methylcobalamin, methylcobalamin plus pregabalin and methylcobalamin plus duloxetine in patients of painful diabetic neuropathy
2021 · Group A · Adults with type 2 diabetes and painful diabetic neuropathy; age range and sex-specific eligibility not stated
1.5 mg12 weeks32
[Treatment of type 2 diabetic peripheral neuropathy patients of qi-yin deficiency complicated phlegm-dampness blocking collaterals syndrome by internal application of qigui mixture and external application of qigui huoxue lotion: a clinical study]
2014 · Control group · Patients with type 2 diabetic peripheral neuropathy and qi-yin deficiency complicated by phlegm-dampness blocking collaterals syndrome
1.5 mg90 days31
PainVision® Apparatus for Assessment of Efficacy of Pulsed Radiofrequency Combined with Pharmacological Therapy in the Treatment of Postherpetic Neuralgia and Correlations with Measurements
2017 · control group · Adults aged 50 years or older with postherpetic neuralgia and severe pain for more than 3 months
1 mg10 days20
Using corneal confocal microscopy to compare Mecobalamin intramuscular injections vs oral tablets in treating diabetic peripheral neuropathy: a RCT
2021 · Oral Mecobalamin tablet group · Adults aged 18–70 with type 2 diabetes and mild to moderate diabetic peripheral neuropathy, without vitamin B12 deficiency
1.5 mg8 weeks19
Effective treatment of cobalamin deficiency with oral cobalamin
1998 · Oral group · Newly diagnosed patients with cobalamin deficiency; age and sex not reported
2 mg120 days18
The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people
2007 · 1000 microg cobalamin group · Dutch elderly people; no diagnosed condition stated
1 mg24 weeks—
High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression
2022 · Vitamin B12 group · Adults aged 18–58 years, mainly young students; no diagnosed condition specified
1 mg5 weeks—
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
2010 · B vitamins · Patients with recent stroke or transient ischaemic attack within the past 7 months
500 mcg1241 days4,089
Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial
2012 · B vitamins · Patients with recent stroke or transient ischemic attack
500 mcg1241 days4,082
Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
2012 · B-vitamins group · Adults with a stroke or transient ischaemic attack within the previous 7 months; men and women, age not restricted
500 mcg1241 days4,040
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial
2008 · Active treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three cardiovascular risk factors
1 mg2665 days2,721
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study
2009 · folic acid/B6/B12 group · Women at high risk of cardiovascular disease, with preexisting cardiovascular disease or at least three coronary risk factors; women included in these AMD analyses had no AMD diagnosis at baseline.
1 mg2665 days2,607
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial
2009 · Active treatment · Women aged 45 years or older at high risk for cardiovascular disease, without diabetes at baseline
1 mg2665 days2,132
Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women
2016 · combination treatment group · Women with preexisting cardiovascular disease or at least three coronary risk factors; ages 40 and older
1 mg2665 days1,969
B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial
2014 · vitamins · Community-dwelling adults aged 50 years or over with DSM-IV-TR major depression
500 mcg52 weeks77
Homocysteine lowering with folic acid and B vitamins in vascular disease
2006 · active-treatment group · Patients aged 55 years or older with vascular disease or diabetes
1 mg5 years—
Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial
2008 · combined folic acid/vitamin B6/vitamin B12 treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three coronary risk factors
1 mg2666 days—
Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial
2009 · vitamin therapy group · Adults with known cardiovascular disease
1 mg5 years—
B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial
2010 · B-vitamins · Stroke survivors; age and sex not specified
500 mcg383 days—
Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial
2014 · vitamin B-12 plus folic acid group · Adults aged 65 years or older with elevated plasma homocysteine concentrations (12–50 μmol/L)
500 mcg2 years—
Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial
2019 · B vitamins · B-PROOF trial participants; age and specific condition not stated in the abstract
500 mcg3 years—
Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study
2009 · Group DB (combination therapy) · Adults with acute lumbago
2 mg7 days187
Vitamin B-12 supplementation improves arterial function in vegetarians with subnormal vitamin B-12 status
2012 · Vitamin B-12 · Adult vegetarians with subnormal vitamin B-12 status; mean age 45 years, 44% male
500 mcg12 weeks43
Vitamin B-12 supplementation improves arterial function in vegetarians with subnormal vitamin B-12 status
2012 · Open-label vitamin B-12 · Adult vegetarians with subnormal vitamin B-12 status; 41 participants completed this phase
500 mcg24 weeks41
Efficacy of Danzhixiaoyao tablets combined with methylcobalamin tablets in the treatment of burning mouth syndrome: an open-label, randomized controlled trial
2024 · Trial group · Adults aged 18–75 with burning mouth syndrome; gender not limited
1.5 mg4 weeks39
Therapeutic efficacy of "Milgamma" in patients with painful diabetic neuropathy
1997 · Milgamma group · Adults with diabetes and painful peripheral polyneuropathy
1 mg90 days30
Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin
2000 · Vitamin B(12) · Patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin who had peripheral polyneuropathy
500 mcg4 weeks12
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial
2008 · folic acid plus vitamin B12 plus vitamin B6 · Adults undergoing coronary angiography with coronary artery disease or aortic valve stenosis
400 mcg165 weeks772
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial
2008 · folic acid plus vitamin B12 · Adults undergoing coronary angiography with coronary artery disease or aortic valve stenosis
400 mcg165 weeks772
Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial
2002 · homocysteine-lowering therapy · Patients with coronary artery disease after successful percutaneous coronary intervention; age and sex not specified
400 mcg26 weeks272
Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial
2005 · daily oral treatment with folate and mecobalamin · Adults aged 65 years or older with residual hemiplegia at least 1 year after a first ischemic stroke
1.5 mg2 years—
Effectiveness of homocysteine lowering vitamins in prevention of thrombotic tendency at high altitude area: A randomized field trial
2015 · intervention · Indian soldiers freshly inducted to a high-altitude area
1 mg2 years—
Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis
2013 · B-vitamins · Patients with previous stroke or transient ischemic attack who were cognitively unimpaired at the cognitive assessment
500 mcg1241 days1,110
Vitamin B12 and Folic Acid Improve Gross Motor and Problem-Solving Skills in Young North Indian Children: A Randomized Placebo-Controlled Trial
2015 · Vitamin B12 · Children aged 6–30 months from low- to middle-socioeconomic-class families in New Delhi, India
1.8 mcg26 weeks109
Folate and Vitamin B(12)-Related Biomarkers in Relation to Brain Volumes
2016 · B-vitamin group · Adults aged 65 years or older with mildly elevated plasma homocysteine (12–50 µmol/L)
500 mcg2 years106
High-dose Vitamin-B6 reduces sensory over-responsivity
2024 · Vitamin-B12 · Adults aged 18–60 from a general population sample; the analysed high-SOR subgroup had high baseline sensory over-responsivity scores.
1 g40 days106
DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
2022 · B-vitamin group · Men and women aged 65 years and older with elevated plasma homocysteine levels (12–50 µmol/L), cognitively healthy
500 mcg2 years94
TangBi Formula for Painful Diabetic Distal Symmetric Polyneuropathy: A Multicenter, Randomized, Double-Blind, Placebo-Controlled and Parallel-Group Trial
2025 · Control (placebo) · Chinese adults aged 40–79 with physician-diagnosed painful diabetic distal symmetric polyneuropathy
1.5 g24 weeks93
A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I-II Cervical Sprains
2024 · Dexketoprofen/vitamin B · Adults aged 18 years or older, both sexes, with grade I–II post-traumatic cervical sprain and acute pain
1.5 mg7 days83
Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages
2002 · vitamin B-12 · healthy younger, middle-aged and older women
15 mcg5 weeks—
The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people
2007 · cobalamin plus folic acid group · Dutch elderly people; no diagnosed condition stated
1 mg24 weeks—
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
2008 · B vitamin group · Women aged 65 years or older with cardiovascular disease or at least three coronary risk factors; female health professionals
1 mg2411 days—
Efficacy and tolerability of advanced glycation end-products inhibitor in osteoarthritis: a randomized, double-blind, placebo-controlled study
2013 · AGEs inhibitor (drug) group · Adults with primary osteoarthritis meeting American College of Rheumatology classification criteria; mean age 57.26 years; 26 women and 4 men in the study overall
1.5 mg24 weeks—
Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT
2014 · B-vitamin group · Adults aged 65 years and older with homocysteine levels of 12–50 µmol/L
500 mcg2 years—
Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial
2015 · B-vitamin supplementation · Adults aged at least 65 years with hyperhomocysteinemia (12–50 μmol/l)
500 mcg2 years—
Effects of Two-Year Vitamin B(12) and Folic Acid Supplementation on Depressive Symptoms and Quality of Life in Older Adults with Elevated Homocysteine Concentrations: Additional Results from the B-PROOF Study, an RCT
2016 · intervention group · Adults aged 65 years or older from the general population with elevated homocysteine concentrations (12–50 µmol/L)
500 mcg2 years—
B-vitamins and body composition: integrating observational and experimental evidence from the B-PROOF study
2020 · intervention group · Adults aged 65 years and older with elevated homocysteine levels (12–50 µmol/L)
500 mcg2 years—
A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients
2020 · B vitamins supplementation · Adults aged 65 years or older with mild cognitive impairment and serum homocysteine ≥10.0 μmol/L
500 mcg2 years—
B Vitamin Supplementation Slows Cognitive Decline in Mild Cognitive Impairment Patients with Frontal Lobe Atrophy
2022 · B vitamin supplementation · Mild cognitive impairment outpatients; age and sex not specified
500 mcg2 years—
Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers, Combined with Dapagliflozin as Type 2 Diabetes Mellitus Routine Treatment: A Controlled Randomized, Double-blind Trial
2025 · Group II (dapagliflozin + vitamin B12) · Adults aged 19–76 with type 2 diabetes, treated with dapagliflozin, and serum vitamin B12 below 223 pg/mL
500 mcg1 year80
Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial
2020 · Group B · Patients with type 2 diabetes mellitus on stable oral antidiabetic drugs
500 mcg8 weeks20
Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease
2010 · Hcy-lowering therapy · Patients with Parkinson's disease, low bone mineral density, and taking levodopa; age and sex not reported
1.5 mg1 year—
Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly
2004 · special nutritional formula · Healthy adults aged 70 years or older with Mini Mental score ≥22
3.8 mcg1 year30
Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren
2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified
2 mcg335 days—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
2.6 mcg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women
50 mcg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women
50 mcg——
Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis
2013 · AGE-S · Subjects evaluated for coronary artery calcium; age, sex, and specific condition are not stated
100 mcg1 year—
Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms--the Beyond Ageing Project: a randomized controlled trial
2012 · daily oral folic acid + vitamin B-12 supplementation · Adults aged 60–74 with elevated psychological distress
100 mcg2 years450
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study
2009 · vitamin group · Adults aged 21 years or older with advanced chronic kidney disease or end-stage renal disease and high plasma homocysteine
2 mg1128 days339
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial
2009 · B-vitamin group · Men and postmenopausal women aged 40 years or older with fasting total homocysteine ≥8.5 μmol/L and no clinical signs or symptoms of cardiovascular disease
400 mcg1132 days254
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
2008 · high-dose supplement group · Adults over 50 with mild to moderate probable Alzheimer disease and normal vitamin B12 and folate levels
1 mg548 days240
[Results of a double-blind study of diclofenac + vitamin B1, B6, B12 versus diclofenac in patients with acute pain of the lumbar vertebrae. A multicenter study]
1990 · Diclofenac plus vitamins B1, B6, and B12 · Patients with acute pain of the lumbar vertebrae; age and sex not specified
1.5 mg2 weeks184
Clinical Trial Assessing the Efficacy of Gabapentin Plus B Complex (B1/B12) versus Pregabalin for Treating Painful Diabetic Neuropathy
2016 · Gabapentin/B1/B12 group · Adults aged 18–65 with type 1 or 2 diabetes and painful diabetic neuropathy
200 mcg12 weeks173
Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial
2008 · treatment with vitamins · Men aged 75 years and older, free of clinically significant depression at baseline
400 mcg2 years150
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial
2012 · B-vitamin group · Adults aged 70 years or older with mild cognitive impairment
500 mcg2 years133
Vitamin B12 and Folic Acid Improve Gross Motor and Problem-Solving Skills in Young North Indian Children: A Randomized Placebo-Controlled Trial
2015 · Vitamin B12 & Folic Acid · Children aged 6–30 months from low- to middle-socioeconomic-class families in New Delhi, India
1.8 mcg26 weeks101
TangBi Formula for Painful Diabetic Distal Symmetric Polyneuropathy: A Multicenter, Randomized, Double-Blind, Placebo-Controlled and Parallel-Group Trial
2025 · TangBi Formula · Chinese adults aged 40–79 with physician-diagnosed painful diabetic distal symmetric polyneuropathy
1.5 g24 weeks93
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
2010 · Active treatment group · Adults aged 70 years or older with mild cognitive impairment
500 mcg2 years85
[Effect of mecobalamin on diabetic neuropathies. Beijing Methycobal Clinical Trial Collaborative Group]
1999 · mecobalamin group · Patients with non-insulin-dependent diabetes mellitus and diabetic neuropathy; age and sex not reported
1.5 mg12 weeks62
Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine
2000 · Folic acid and vitamin B(12) · Men aged 39–67 years with coronary heart disease
1 mg8 weeks59
[Effect of mecobalamin on diabetic neuropathies. Beijing Methycobal Clinical Trial Collaborative Group]
1999 · vitamin B(12) control group · Patients with non-insulin-dependent diabetes mellitus and diabetic neuropathy; age and sex not reported
1.5 mg12 weeks46
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · combined therapy · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
400 mcg6 weeks36
Folate and vitamin B12 supplementation in patients with schizophrenia and low serum folate level: A 24-week randomized, double-blind, placebo-controlled study
2026 · folate group · Patients with schizophrenia and serum folate levels lower than 6 mg/L
500 mcg24 weeks36
[Effect of the Nucleus CMP forte in 46 patients with progressive spastic paraparesis. Randomized and blind study]
1996 · Nucleus CMP forte · Adults aged 25–79 with idiopathic or HTLV-1-associated progressive spastic paraparesis
6 mg26 weeks22
PainVision® Apparatus for Assessment of Efficacy of Pulsed Radiofrequency Combined with Pharmacological Therapy in the Treatment of Postherpetic Neuralgia and Correlations with Measurements
2017 · PRF group · Adults aged 50 years or older with postherpetic neuralgia and severe pain for more than 3 months
1 mg10 days20
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · group V · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
400 mcg6 weeks18
Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study
2005 · Vitamin therapy · Community-dwelling elderly adults, median age 76 years; both sexes; vitamin deficiencies were present in a subset
500 mcg120 days—
Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet
2009 · B vitamin supplementation · Adults aged 45–64 years with longstanding coeliac disease, on a strict gluten-free diet for several years
500 mcg26 weeks—
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people
2011 · supplement group · Older people with mild to moderate Alzheimer disease or vascular dementia
1 mg2 years—
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
2011 · Folic acid and vitamin B12, without vitamin B6 · Adults with stable coronary artery disease; mean age 57.8 years; sex not specified
400 mcg2 years—
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
2011 · Folic acid and vitamin B12 plus vitamin B6 · Adults with stable coronary artery disease; mean age 57.8 years; sex not specified
400 mcg2 years—
B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial
2014 · B vitamins only · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke
20 mcg1716 days—
B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial
2017 · treatment group (high-dose vitamin group) · Men and women aged 35–75 with stable kidney function for at least 6 months after kidney transplantation and elevated plasma homocysteine
1 mg2008 days—
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B(12), B(6), and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis
2019 · B-vitamin supplement group · Patients with first-episode psychosis; age and sex not specified
400 mcg12 weeks—
A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)
2000 · combination group · Patients with primary hypercholesterolaemia; age and sex not reported
800 mcg6 weeks—
Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12)
2020 · Oral route · Adults aged 65 years or older with vitamin B12 deficiency
1 mg1 year140
Phase II Study of a Multi-center Randomized Controlled Trial to Evaluate Oral Vitamin B12 Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients
2022 · Vitamin B12 1,500 μg/day arm · Patients with vitamin B12 deficiency after total gastrectomy for gastric cancer
1.5 mg90 days38
Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open-label, parallel-group study
2011 · oral B(12) group · Adults with low cobalamin levels (<350 pg/mL), aged 60 years or older or aged 18 years or older with gastrointestinal abnormalities or a restricted diet
1 mg90 days24
Efficacy of oral compared with intramuscular vitamin B-12 supplementation after Roux-en-Y gastric bypass: a randomized controlled trial
2018 · oral B-12 · Patients with subnormal serum vitamin B-12 concentrations after Roux-en-Y gastric bypass
1 mg26 weeks23
Sublingual vitamin B12 compared to intramuscular injection in patients with type 2 diabetes treated with metformin: a randomised trial
2016 · sublingual tablet group · Adults with type 2 diabetes treated with metformin and serum vitamin B12 below 220 pmol/L; mean age 64.2 years
1 mg90 days19
Early biomarker response and patient preferences to oral and intramuscular vitamin B12 substitution in primary care: a randomised parallel-group trial
2017 · O-oral · Adults with vitamin B12 deficiency in a primary-care population; age range and sex distribution by arm not reported
1 mg4 weeks19
Effect of supplementation with cobalamin carried either by a milk product or a capsule in mildly cobalamin-deficient elderly Dutch persons
2005 · fortified-milk group · Mildly cobalamin-deficient elderly Dutch persons
1 mg12 weeks—
Effect of supplementation with cobalamin carried either by a milk product or a capsule in mildly cobalamin-deficient elderly Dutch persons
2005 · cobalamin capsule group · Mildly cobalamin-deficient elderly Dutch persons
1 mg12 weeks—
Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial
2021 · B12 group · Adults over 18 with type 2 diabetes, established peripheral and autonomic neuropathy, good glycemic control, at least 4 years of metformin treatment, and low vitamin B12 levels
1 mg1 year—
Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving
2018 · MMN · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum
5.2 mg1 year239
Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving
2018 · LNS · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum
5.2 mg1 year234
A smartphone application to improve adherence to vitamin and mineral supplementation after bariatric surgery
2022 · Intervention group · Adults aged over 18 to 60 years undergoing gastric bypass or sleeve gastrectomy
1 mg1 year71
Effect of zinc plus multivitamin supplementation on growth in school children
2016 · Chelated zinc plus multivitamins · Healthy Thai schoolchildren aged 4–13 years
10 mcg26 weeks70
Investigating the Effects of a Multinutrient Supplement on Cognition, Mood and Biochemical Markers in Middle-Aged Adults with 'Optimal' and 'Sub-Optimal' Diets: A Randomized Double Blind Placebo Controlled Trial
2022 · active supplementation · Adults aged 40–65 years, healthy and without neurological, cognitive, mood or psychiatric disorders; participants had either an optimal or sub-optimal diet
50 mcg12 weeks70
A smartphone application to improve adherence to vitamin and mineral supplementation after bariatric surgery
2022 · Control group · Adults aged over 18 to 60 years undergoing gastric bypass or sleeve gastrectomy
1 mg1 year69
Evaluation of the Efficacy of the Addition of a Combination of Pyrimidine Nucleotides and Vitamin B1 and B12 to Standard Treatment in the Management of Painful Radiculopathy and in the Quality of Life of Patients
2024 · experimental treatment group · Adults aged 18–85 of both sexes with painful radiculopathy of any etiology, upper neuropathic pain, and pain VAS ≥60 mm
1.49 g8 weeks63
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · NF group, 3-month blinded trial · Community-dwelling adults aged 18–86 years, both sexes, without dementia or clinical memory difficulties
6 mcg90 days59
Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study
2022 · Mg-Teadiola · Adults aged 18–65, either sex, otherwise healthy and chronically stressed (DASS-42 stress score ≥14)
1.25 mcg4 weeks51
Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients
2007 · mecobalamin (B12) + multivitamin supplement · Taiwanese men and women aged over 50 with mild to moderate Alzheimer's disease and normal folic acid and vitamin B12 concentrations
500 mg26 weeks45
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Nutritional intervention group · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
2 mcg26 weeks40
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Placebo group receiving open-label TAP in follow-up · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
2 mcg13 weeks40
Effects of Low-Dose Dairy Protein Plus Micronutrient Supplementation during Resistance Exercise on Muscle Mass and Physical Performance in Older Adults: A Randomized, Controlled Trial
2018 · ExPM (resistance exercise plus low-dose dairy protein and micronutrient supplementation) · Adults aged 65–80 years, non-disabled and not exercising regularly
12 mcg12 weeks40
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · Open-label NF group, separate 6-month trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties
6 mcg26 weeks38
Association of serum homocysteine, folate, and vitamin B(12) and mood following the Swank and Wahls elimination dietary interventions in relapsing-remitting multiple sclerosis: Secondary analysis of the WAVES trial
2023 · Swank diet group · Adults with relapsing-remitting multiple sclerosis and moderate to severe fatigue; ages and sex not specified
1 g24 weeks37
Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
2024 · 10-element combination tablet · Overweight or obese adults with type 2 diabetes and mild-to-moderate painful diabetic neuropathy; mean age 63 years
5 mcg26 weeks36
Association of serum homocysteine, folate, and vitamin B(12) and mood following the Swank and Wahls elimination dietary interventions in relapsing-remitting multiple sclerosis: Secondary analysis of the WAVES trial
2023 · Wahls diet group · Adults with relapsing-remitting multiple sclerosis and moderate to severe fatigue; ages and sex not specified
1 g24 weeks35
A functional evaluation of anti-fatigue and exercise performance improvement following vitamin B complex supplementation in healthy humans, a randomized double-blind trial
2023 · Ex PLUS® group · Healthy male and female non-athletes aged 20–30
750 mcg4 weeks32
Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males
2017 · PWS · Apparently healthy, resistance-trained males; mean age about 21 years
70 mg8 weeks27
Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males
2017 · PWS + S · Apparently healthy, resistance-trained males; mean age about 22 years
70 mg8 weeks26
Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance
2017 · PWS · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years
70 mg1 day25
Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance
2017 · PWS + S · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years
70 mg1 day25
Short-Term Effects of a Ready-to-Drink Pre-Workout Beverage on Exercise Performance and Recovery
2017 · RTD · Recreationally active men and women aged 18–40 years with at least six months of resistance-training experience
45 mcg7 days25
Effects of Macuprev(®) Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up
2019 · AMD-M group · Adults with intermediate age-related macular degeneration; 9 male and 21 female enrolled overall, mean age 69.32 years
18 mg26 weeks15
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study
2025 · addOPC group · Adults with Parkinson's disease receiving levodopa-carbidopa intestinal gel and experiencing nocturnal, morning, or afternoon akinesia
5 mcg1 year11
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study
2025 · nOPC group · Adults with Parkinson's disease receiving levodopa-carbidopa intestinal gel and experiencing nocturnal, morning, or afternoon akinesia
5 mcg1 year11
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · NF group, 2-week blinded trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties
6 mcg2 weeks—
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
2011 · Group MVB · Patients with type 2 diabetes
10 mcg120 days—
B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial
2014 · B vitamins plus n-3 fatty acids · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke
20 mcg1716 days—
Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance
2014 · B vitamin supplementation group · Healthy preschool children selected for low urinary folate-status ranking
1.2 mcg90 days—
Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly
2015 · treatment group · Healthy adults aged 60–74 years
10 mcg1 year—
Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine
2002 · vitamin B(12) group · Japanese patients with ischemic stroke in the convalescent stage
1.5 mg8 weeks63
Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study
2003 · p.o. group · Patients aged 16 years or older with megaloblastic anemia due to cobalamin deficiency
1 mg90 days26
Oral vitamin B12 for patients suspected of subtle cobalamin deficiency: a multicentre pragmatic randomised controlled trial
2011 · Oral B12 · Adults aged 18–91 with suspected subtle cobalamin deficiency and serum vitamin B12 concentrations of 125–200 pM/l
1 mg4 weeks26
The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial
2022 · Vitamin B12 group · Men and women aged 18–80 years with ultrasound-diagnosed NAFLD and increased serum ALT
1 mg12 weeks20
Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial
2005 · 1000 mug/day cyanocobalamin group · Older people with mild vitamin B12 deficiency
1 mg16 weeks—
Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment
2006 · Elevated MMA group treated with cyanocobalamin · Elderly people with elevated serum MMA, indicating cobalamin deficiency
1 mg90 days—
Effect of vitamin B-12 and n-3 polyunsaturated fatty acids on plasma homocysteine, ferritin, C-reaction protein, and other cardiovascular risk factors: a randomized controlled trial
2015 · vitamin B-12 group · Eligible subjects; age, sex, and health condition not specified
1 mg8 weeks—
Effects of vitamin B12 on performance and circadian rhythm in normal subjects
1996 · cyano-(CB12) group · Healthy women and men; mean ages 35 years for women and 37 years for men
3 mg2 weeks—
Effects of vitamin B12 on performance and circadian rhythm in normal subjects
1996 · methylcobalamin (MB12) group · Healthy women and men; mean ages 35 years for women and 37 years for men
3 mg2 weeks—
Efficacy of L-methylfolate and methylcobalamin in treating resistant hypertension associated with elevated serum homocysteine in hemodialysis patients
2026 · treatment group · Adults with end-stage renal disease undergoing maintenance hemodialysis, resistant hypertension, and elevated homocysteine; ages 25–73 in the analyzed treatment group
1 mg90 days25
Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial
2020 · Group C · Patients with type 2 diabetes mellitus on stable oral antidiabetic drugs
500 mcg8 weeks20
Lowering homocysteine with B vitamins has no effect on blood pressure in older adults
2007 · Vitamins group · Healthy adults aged 65 years or older with homocysteine concentrations of at least 13 micromol/L
500 mcg2 years—
Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route
2003 · sublingual B12 · People with low serum cobalamin concentrations
500 mcg4 weeks—
Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route
2003 · oral B12 · People with low serum cobalamin concentrations
500 mcg4 weeks—
A vitamin B-12 supplement of 500 μg/d for eight weeks does not normalize urinary methylmalonic acid or other biomarkers of vitamin B-12 status in elderly people with moderately poor vitamin B-12 status
2013 · 500 μg/d cyanocobalamin · Elderly people with moderately poor vitamin B-12 status
500 mcg8 weeks—
A 2-Year Randomized Controlled Trial With Low-Dose B-Vitamin Supplementation Shows Benefits on Bone Mineral Density in Adults With Lower B12 Status
2022 · B-vitamin treatment · Community-dwelling adults aged 50 years or older; men and women; no specific diagnosed condition, and not currently taking B-vitamin supplements at screening
10 mcg2 years103
Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial
2009 · AGE+S · Intermediate-risk adults, mean age 60 ± 9 years; 79% male
100 mcg1 year—
Folic acid and vitamin B(12) supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trial
2013 · vitamin group · Women aged 65–93 years with homocysteine levels greater than 10 μmol/L
1 mg120 days17
Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption
2001 · 5000 microg once a week · Patients with cobalamin deficiency and well-established food-cobalamin malabsorption; ages and sex not stated
714 mcg90 days—
Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial
2005 · 500 mug/day cyanocobalamin group · Older people with mild vitamin B12 deficiency
500 mcg16 weeks—
Effects of dietary intervention on vitamin B(12) status and cognitive level of 18-month-old toddlers in high-poverty areas: a cluster-randomized controlled trial
2019 · meat group · Infants assigned at 6 months of age in rural China; term, healthy, exclusively breastfed infants without serious neonatal complications
0.21 mcg1 year461
Effects of dietary intervention on vitamin B(12) status and cognitive level of 18-month-old toddlers in high-poverty areas: a cluster-randomized controlled trial
2019 · fortified cereal group · Infants assigned at 6 months of age in rural China; term, healthy, exclusively breastfed infants without serious neonatal complications
0.2 mcg1 year419
Effect of Combined Treatment With Folic Acid, Vitamin B(6), and Vitamin B(12) on Plasma Biomarkers of Inflammation and Endothelial Dysfunction in Women
2018 · Folic Acid/B6/B12 · Adult women at increased cardiovascular risk, with pre-existing cardiovascular disease or at least three coronary risk factors
1 mg2665 days150
Preventing vitamin B12 deficiency in South Asian women of childbearing age: a randomised controlled trial comparing an oral vitamin B12 supplement with B12 dietary advice
2014 · B12 Supplement · South Asian women aged 18–50 before conception
6 mcg26 weeks21
Cyano-B12 or Whey Powder with Endogenous Hydroxo-B12 for Supplementation in B12 Deficient Lactovegetarians
2019 · capsule group · Lactovegetarians aged 18–50 years with low vitamin B12 status
5.6 mcg8 weeks17
A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations
2002 · 10 microg oral cyanocobalamin group · Older inpatients with serum vitamin B12 concentrations of 100–150 pmol/L and no pernicious anemia or other stated malabsorption disorder; mean age 81.4 years; sex not specified
10 mcg30 days10
A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations
2002 · 50 microg oral cyanocobalamin group · Older inpatients with serum vitamin B12 concentrations of 100–150 pmol/L and no pernicious anemia or other stated malabsorption disorder; mean age 81.4 years; sex not specified
50 mcg30 days10
Very low oral doses of vitamin B-12 increase serum concentrations in elderly subjects with food-bound vitamin B-12 malabsorption
2007 · 2.5 microg/d group · Elderly subjects with food-bound vitamin B-12 malabsorption and subclinical vitamin B-12 deficiency
2.5 mcg30 days—
Very low oral doses of vitamin B-12 increase serum concentrations in elderly subjects with food-bound vitamin B-12 malabsorption
2007 · 5 microg/d group · Elderly subjects with food-bound vitamin B-12 malabsorption and subclinical vitamin B-12 deficiency
5 mcg30 days—
Very low oral doses of vitamin B-12 increase serum concentrations in elderly subjects with food-bound vitamin B-12 malabsorption
2007 · 10 microg/d group · Elderly subjects with food-bound vitamin B-12 malabsorption and subclinical vitamin B-12 deficiency
10 mcg30 days—
Very low oral doses of vitamin B-12 increase serum concentrations in elderly subjects with food-bound vitamin B-12 malabsorption
2007 · 20 microg/d group · Elderly subjects with food-bound vitamin B-12 malabsorption and subclinical vitamin B-12 deficiency
20 mcg30 days—
Very low oral doses of vitamin B-12 increase serum concentrations in elderly subjects with food-bound vitamin B-12 malabsorption
2007 · 40 microg/d group · Elderly subjects with food-bound vitamin B-12 malabsorption and subclinical vitamin B-12 deficiency
40 mcg30 days—
Very low oral doses of vitamin B-12 increase serum concentrations in elderly subjects with food-bound vitamin B-12 malabsorption
2007 · 80 microg/d group · Elderly subjects with food-bound vitamin B-12 malabsorption and subclinical vitamin B-12 deficiency
80 mcg30 days—
A vitamin B-12 supplement of 500 μg/d for eight weeks does not normalize urinary methylmalonic acid or other biomarkers of vitamin B-12 status in elderly people with moderately poor vitamin B-12 status
2013 · 100 μg/d cyanocobalamin · Elderly people with moderately poor vitamin B-12 status
100 mcg8 weeks—
A vitamin B-12 supplement of 500 μg/d for eight weeks does not normalize urinary methylmalonic acid or other biomarkers of vitamin B-12 status in elderly people with moderately poor vitamin B-12 status
2013 · 10 μg/d cyanocobalamin · Elderly people with moderately poor vitamin B-12 status
10 mcg8 weeks—
Effect of two different sublingual dosages of vitamin B(12) on cobalamin nutritional status in vegans and vegetarians with a marginal deficiency: A randomized controlled trial
2019 · test group Ld (low dose) · Vegans and vegetarians with marginal vitamin B12 deficiency; age and sex not specified
50 mcg12 weeks—
Effect of two different sublingual dosages of vitamin B(12) on cobalamin nutritional status in vegans and vegetarians with a marginal deficiency: A randomized controlled trial
2019 · control group Hd (high dose) · Vegans and vegetarians with marginal vitamin B12 deficiency; age and sex not specified
286 mcg12 weeks—
Vitamin B12-fortified toothpaste improves vitamin status in elderly people: a randomized, double-blind, placebo-controlled study
2019 · vitamin B12 toothpaste group · elderly people; age range and sex not specified
7 mcg90 days—
Comparative Bioavailability of Synthetic B12 and Dietary Vitamin B12 Present in Cow and Buffalo Milk: A Prospective Study in Lactovegetarian Indians
2019 · CN group (capsule group) · Lactovegetarian Indian adults aged 18–50 with low vitamin B12 status and no recognized chronic systemic disease
1.52 mcg4 weeks—
Comparative Bioavailability of Synthetic B12 and Dietary Vitamin B12 Present in Cow and Buffalo Milk: A Prospective Study in Lactovegetarian Indians
2019 · Cow milk group · Lactovegetarian Indian adults aged 18–50 with low vitamin B12 status and no recognized chronic systemic disease
1.56 mcg4 weeks—
Comparative Bioavailability of Synthetic B12 and Dietary Vitamin B12 Present in Cow and Buffalo Milk: A Prospective Study in Lactovegetarian Indians
2019 · Buffalo milk group · Lactovegetarian Indian adults aged 18–50 with low vitamin B12 status and no recognized chronic systemic disease
1.56 mcg4 weeks—
Efficacy of B(12) Fortified Nutrient Bar and Yogurt in Improving Plasma B12 Concentrations-Results From 2 Double-Blind Randomized Placebo Controlled Trials
2021 · Children receiving nutrient bar fortified with B12 · Healthy children aged 10–13 years
2 mcg120 days—
Efficacy of B(12) Fortified Nutrient Bar and Yogurt in Improving Plasma B12 Concentrations-Results From 2 Double-Blind Randomized Placebo Controlled Trials
2021 · Children receiving nutrient bar fortified with multiple micronutrients · Healthy children aged 10–13 years
1.8 mcg120 days—
Efficacy of B(12) Fortified Nutrient Bar and Yogurt in Improving Plasma B12 Concentrations-Results From 2 Double-Blind Randomized Placebo Controlled Trials
2021 · Adults receiving yogurt fortified with B12 · Healthy adults aged 18–50 years
2 mcg120 days—
The effects of prenatal and postnatal high-dose vitamin B-12 supplementation on human milk vitamin B-12: a randomized, double-blind, placebo-controlled trial in Tanzania
2024 · Prenatal supplement · Pregnant women enrolled at 12–27 weeks of gestation in Tanzania
50 mcg——
The effects of prenatal and postnatal high-dose vitamin B-12 supplementation on human milk vitamin B-12: a randomized, double-blind, placebo-controlled trial in Tanzania
2024 · Postnatal supplement · Women 6 weeks to 18 months postpartum in Tanzania
50 mcg502 days—
Daily Folic Acid and/or Vitamin B12 Supplementation Between 6 and 30 Months of Age and Cardiometabolic Risk Markers After 6-7 Years: A Follow-Up of a Randomized Controlled Trial
2023 · Vitamin B12 only · Children aged 6–30 months at enrollment
1.8 mcg180 days201
Effect of Folic Acid, Betaine, Vitamin B₆, and Vitamin B12 on Homocysteine and Dimethylglycine Levels in Middle-Aged Men Drinking White Wine
2016 · Vitamin B12 group · Healthy men aged 37–65 years who were moderate alcohol consumers
200 mcg4 weeks23
A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)
2000 · vitamins alone group · Patients with primary hypercholesterolaemia; age and sex not reported
800 mcg6 weeks—
Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption
2001 · 3000 microg once a week · Patients with cobalamin deficiency and well-established food-cobalamin malabsorption; ages and sex not stated
429 mcg90 days—
Preoperative oral B vitamins prevent nitrous oxide-induced postoperative plasma homocysteine increases
2001 · Vitamin group · Patients undergoing elective revision knee or hip arthroplasty, scheduled for surgery lasting longer than 3 hours
500 mcg7 days—
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial
2005 · vitamin therapy · Patients with recent transient ischemic attack or stroke; age and sex not reported
500 mcg26 weeks—
Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population
2005 · active VITATOPS medication · Patients with stroke or transient ischemic attack
500 mcg26 weeks—
Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial
2005 · 2.5 mug/day cyanocobalamin group · Older people with mild vitamin B12 deficiency
2.5 mcg16 weeks—
Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial
2005 · 100 mug/day cyanocobalamin group · Older people with mild vitamin B12 deficiency
100 mcg16 weeks—
Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial
2005 · 250 mug/day cyanocobalamin group · Older people with mild vitamin B12 deficiency
250 mcg16 weeks—
Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12
2005 · treatment group · Adults aged 60 ± 8 years with carotid intima-media thickness ≥1 mm and at risk of cerebral ischemia
500 mcg1 year—
Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease
2005 · folic acid plus vitamin B-12 · Adults aged 65 years or older with ischemic vascular disease
500 mcg1 year—
Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India
2007 · Vitamin B12 without green leafy vegetables · Non-pregnant vegetarian women aged 20–50 years
250 mcg6 weeks—
Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India
2007 · Vitamin B12 with green leafy vegetables · Non-pregnant vegetarian women aged 20–50 years
250 mcg6 weeks—
Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial
2009 · B-vitamin therapy · Adults with a history of ischemic stroke
500 mcg1461 days—
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India
2010 · B2 F0 (2 μg vitamin B12, no folic acid) · Children and adults from rural families in India; participants included children (mean age 9 years), mothers and fathers, with common vitamin B12 deficiency and elevated homocysteine
2 mcg1 year—
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India
2010 · B10 F0 (10 μg vitamin B12, no folic acid) · Children and adults from rural families in India; participants included children (mean age 9 years), mothers and fathers, with common vitamin B12 deficiency and elevated homocysteine
10 mcg1 year—
Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial
2010 · B-vitamin group · People with type 1 or type 2 diabetes and a clinical diagnosis of diabetic nephropathy
1 mg3 years—
Effect of vitamin B-12 and n-3 polyunsaturated fatty acids on plasma homocysteine, ferritin, C-reaction protein, and other cardiovascular risk factors: a randomized controlled trial
2015 · vitamin B-12+fish oil group · Eligible subjects; age, sex, and health condition not specified
1 mg8 weeks—
Vitamin requirements for the treatment of hyperhomocysteinemia in humans
1994 · vitamin B-12 · men with hyperhomocysteinemia
400 mcg6 weeks—
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers
1998 · 0.4 mg hydroxycobalamin · Healthy volunteers without hyperhomocysteinemia
400 mcg——
Vitamin B-12 supplementation during pregnancy and early lactation increases maternal, breast milk, and infant measures of vitamin B-12 status
2014 · Vitamin B-12 group · Pregnant women in Bangalore, India, enrolled before 14 weeks of gestation; followed through early lactation
50 mcg—183
Bread cofortified with folic acid and vitamin B-12 improves the folate and vitamin B-12 status of healthy older people: a randomized controlled trial
2008 · bread fortified with folic acid and vitamin B-12 · Men and women aged 50–75 years described as healthy older people
9.6 mcg12 weeks72
Vitamin B-12 supplementation of rural Mexican women changes biochemical vitamin B-12 status indicators but does not affect hematology or a bone turnover marker
2012 · vitamin B-12 treatment · Women aged 20–59 years in rural Querétaro, Mexico, stratified by deficient, marginal, or adequate vitamin B-12 status
500 mcg90 days70
Effects of a Novel Dispersible Supplement Containing 2500 IU of Vitamin D and 1000 µg of B12 in Restoring Vitamin D and B12 Insufficiency: A Multicenter, Randomized Controlled Trial
2025 · Group A · Adults aged over 20 and under 80 with vitamin D concentration below 20 ng/mL and vitamin B12 concentration below 250 ng/L
1 mg12 weeks62
Effects of a Novel Dispersible Supplement Containing 2500 IU of Vitamin D and 1000 µg of B12 in Restoring Vitamin D and B12 Insufficiency: A Multicenter, Randomized Controlled Trial
2025 · Group B · Adults aged over 20 and under 80 with vitamin D concentration below 20 ng/mL and vitamin B12 concentration below 250 ng/L
1 mg12 weeks62
Vitamin B-12 Status Differs among Pregnant, Lactating, and Control Women with Equivalent Nutrient Intakes
2015 · Lactating women · Women 5 weeks postpartum
2.6 mcg11 weeks28
Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial
2016 · B-complex · Elderly people
10 mcg23 days27
Vitamin B-12 Status Differs among Pregnant, Lactating, and Control Women with Equivalent Nutrient Intakes
2015 · Pregnant women · Women aged 26–29 weeks of pregnancy
2.6 mcg11 weeks26
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid
2002 · Folic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia
1 mg12 weeks24
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid
2002 · Folinic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia
1 mg12 weeks22
Vitamin B-12 Status Differs among Pregnant, Lactating, and Control Women with Equivalent Nutrient Intakes
2015 · Control women · Nonpregnant, nonlactating women
2.6 mcg11 weeks21
Cyano-B12 or Whey Powder with Endogenous Hydroxo-B12 for Supplementation in B12 Deficient Lactovegetarians
2019 · whey powder group · Lactovegetarians aged 18–50 years with low vitamin B12 status
5.6 mcg8 weeks18
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study
2002 · Vitamin B(12), folic acid, and vitamin B(6) · Patients aged 38–80 years undergoing coronary angiography
400 mcg12 weeks—
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study
2002 · Vitamin B(12) and folic acid · Patients aged 38–80 years undergoing coronary angiography
400 mcg12 weeks—
Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study
2003 · Group A · Patients aged 38–80 years undergoing coronary angiography
400 mcg12 weeks—
A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy
2007 · Group A · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia
30 mcg75 days—
A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy
2007 · Group B · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia
30 mcg75 days—
A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy
2007 · Group C · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia
30 mcg75 days—
Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers only: a randomized clinical trial in Bangladesh
2016 · B12 supplementation · Bangladeshi pregnant women aged 18–35 years, 11–14 weeks pregnant, with hemoglobin <110 g/L
250 mcg——
Effects of Prolonged Whey Protein Supplementation and Resistance Training on Biomarkers of Vitamin B12 Status: A 1-Year Randomized Intervention in Healthy Older Adults (the CALM Study)
2020 · WHEY · Healthy, independent adults aged 65 years or older; men and women
3.1 mcg1 year—
Effects of Prolonged Whey Protein Supplementation and Resistance Training on Biomarkers of Vitamin B12 Status: A 1-Year Randomized Intervention in Healthy Older Adults (the CALM Study)
2020 · COLL · Healthy, independent adults aged 65 years or older; men and women
1.3 mcg1 year—
Effects of Prolonged Whey Protein Supplementation and Resistance Training on Biomarkers of Vitamin B12 Status: A 1-Year Randomized Intervention in Healthy Older Adults (the CALM Study)
2020 · HRTW · Healthy, independent adults aged 65 years or older; men and women; also assigned supervised heavy resistance training
3.1 mcg1 year—
Effects of Prolonged Whey Protein Supplementation and Resistance Training on Biomarkers of Vitamin B12 Status: A 1-Year Randomized Intervention in Healthy Older Adults (the CALM Study)
2020 · LITW · Healthy, independent adults aged 65 years or older; men and women; also assigned home-based light resistance training
3.1 mcg1 year—
Effects of Prolonged Whey Protein Supplementation and Resistance Training on Biomarkers of Vitamin B12 Status: A 1-Year Randomized Intervention in Healthy Older Adults (the CALM Study)
2020 · CARB · Healthy, independent adults aged 65 years or older; men and women
0.3 mcg1 year—
Parenteral vs Oral Vitamin B12 in Children With Nutritional Macrocytic Anemia: A Randomized Controlled Trial
2022 · Group B (oral vitamin B12) · Children aged 2 months–18 years with nutritional macrocytic-megaloblastic anemia
1.5 mg90 days—
One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans
2015 · B-vitamin supplementation · Older German adults, mean age 67 years
500 mcg1 year—
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
5.2 mcg—870
Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh
2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh
2.6 mcg165 days749
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication.
3 mcg24 weeks501
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2.
3 mcg24 weeks201
Daily Folic Acid and/or Vitamin B12 Supplementation Between 6 and 30 Months of Age and Cardiometabolic Risk Markers After 6-7 Years: A Follow-Up of a Randomized Controlled Trial
2023 · Vitamin B12 and folic acid · Children aged 6–30 months at enrollment
1.8 mcg180 days184
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
2.6 mcg—176
Effect of supplementation with a lipid-based nutrient supplement on the micronutrient status of children aged 6-18 months living in the rural region of Intibucá, Honduras
2014 · intervention group · Children enrolled at 5–18 months of age, living in rural Intibucá, Honduras, without stated medical conditions
2.7 mcg1 year160
Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial
2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies
0.9 mcg36 weeks130
Lowering plasma homocysteine concentrations of older men and women with folate, vitamin B-12, and vitamin B-6 does not affect the proportion of (n-3) long chain polyunsaturated fatty acids in plasma phosphatidylcholine
2008 · vitamin group · Men and women aged 65 years or older with plasma homocysteine concentrations of at least 13 micromol/L
500 mcg2 years127
Influence of folic acid and vitamin B12 supplementation on arsenic methylation: A double-blinded, placebo-controlled trial in Bangladeshi children
2024 · FA + B12 supplementation group · Children aged 8–11 years in Bangladesh exposed to drinking-water arsenic above 50 μg/L
5 mcg12 weeks118
Multiple micronutrient supplementation improves vitamin B₁₂ and folate concentrations of HIV infected children in Uganda: a randomized controlled trial
2011 · Multiple micronutrient supplementation (MMS) · HIV-infected children aged 1–5 years
2.4 mcg26 weeks104
Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment
2021 · B-vitamin group · Men and women, mean age 77.6 years, with mild cognitive impairment
500 mcg2 years95
Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial
2015 · high-dose B vitamin supplementation · Adults aged 70 years or older with mild cognitive impairment
500 mcg2 years85
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease
2003 · Daily multivitamin therapy with added vitamin B12 · Adults with end-stage renal disease receiving hemodialysis and with hyperhomocysteinemia
1 mg4 weeks81
A Combined Nutrition and Exercise Intervention Influences Serum Vitamin B-12 and 25-Hydroxyvitamin D and Bone Turnover of Healthy Chinese Middle-Aged and Older Adults
2020 · intervention group · Chinese men and women aged 50 years or older, apparently healthy and community-dwelling
2.9 mcg24 weeks80
Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine
2002 · combined vitamin B(12) and folic acid group · Japanese patients with ischemic stroke in the convalescent stage
1.5 mg8 weeks64
Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study
2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases
2 mcg8 weeks60
Weekly iron as a safe alternative to daily supplementation for nonanemic pregnant women
2006 · Daily supplementation (DS) · Pregnant women with singleton pregnancies, at gestational week 20, with hemoglobin >115 g/L; nonanemic
1 mcg16 weeks56
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
2022 · Folic acid + vitamins B12, B6 · Adults with suspected coronary artery disease undergoing angiography for stable angina; mean age 61.2 years, 71.5% male
400 mcg1387 days52
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
2022 · Folic acid + vitamin B12 · Adults with suspected coronary artery disease undergoing angiography for stable angina; mean age 61.2 years, 71.5% male
400 mcg1387 days52
An Animal-Source Food Supplement Increases Micronutrient Intakes and Iron Status among Reproductive-Age Women in Rural Vietnam
2017 · ASF group · Women aged 18–30 years, nonpregnant, of reproductive age in rural Vietnam
5.5 mcg26 weeks47
[Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients]
2012 · group 2 · Patients with essential hypertension; age and sex not reported
1 mg12 weeks40
[Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients]
2012 · group 3 · Patients with essential hypertension; age and sex not reported
1 mg12 weeks40
Assessment of vitamin A, vitamin B(2), vitamin B(12), vitamin K, folate, and choline status following 4 months of multinutrient supplementation in healthy vegans: a randomised, double-blind, placebo-controlled trial
2025 · INT (intervention group; standard and double omega-3 dosage subgroups) · Healthy adults aged 18 years or older who had followed a vegan diet for at least 1 year; no diagnosed vitamin or mineral deficiency
100 mcg120 days35
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Supraphysiological daily-dose regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
1 mg1 year33
Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults
1998 · supplemented group · Young Australian adults aged 18–32 years; males and females; not folate deficient, with 4.4% vitamin B12 deficient
7 mcg26 weeks31
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Natural vitamin B complex (group N) · Healthy adults; age range and sex not specified
8.85 mcg6 weeks30
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Synthetic vitamin B complex (group S) · Healthy adults; age range and sex not specified
8.85 mcg6 weeks30
Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation
2005 · open therapy with vitamins · Adults with ischemic heart disease and plasma homocysteine at least 15.0 micromol/L
1 mg90 days29
Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation
2005 · Hyperhomocysteinemia patients treated with folic acid and vitamin B12 · Renal transplant recipients with hyperhomocysteinemia
500 mg90 days29
The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes
2006 · folic acid, vitamin B12 and vitamin B6 supplementation group · Both-sex participants without folate deficiency; age not reported
20 mcg7 days29
Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients
2003 · group A · Adults with hyperhomocysteinemia who were stable renal-transplant recipients
400 mcg26 weeks28
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Daily renal multivitamin regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
400 mcg1 year27
Effect of Methylfolate, Pyridoxal-5'-Phosphate, and Methylcobalamin (Soloways(TM)) Supplementation on Homocysteine and Low-Density Lipoprotein Cholesterol Levels in Patients with Methylenetetrahydrofolate Reductase, Methionine Synthase, and Methionine Synthase Reductase Polymorphisms: A Randomized Controlled Trial
2024 · methylfolate, P5P, and methylcobalamin · Adults aged 40–75 with elevated homocysteine, LDL-C of 70–190 mg/dL, and at least one minor allele in a specified MTHFR, MTR, or MTRR polymorphism
1 mg180 days27
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2000 · FA group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg12 weeks25
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2000 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg12 weeks25
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis
1 mg12 weeks25
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis
1 mg12 weeks25
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2001 · L-folinic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg12 weeks24
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg12 weeks24
B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke
2004 · B-group vitamin supplements · Patients with acute ischaemic stroke, enrolled within 12 hours of symptom onset; age and sex not specified
400 mcg2 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
400 mcg2 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
400 mcg2 weeks24
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 1 · Chronic, stable renal transplant recipients; age and sex not stated
400 mcg12 weeks20
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 2 · Chronic, stable renal transplant recipients; age and sex not stated
400 mcg12 weeks20
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 3 · Chronic, stable renal transplant recipients; age and sex not stated
400 mcg12 weeks20
Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial
2005 · group 2 · Women with polycystic ovarian syndrome treated with metformin; age not reported
2 mg90 days20
Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation
2002 · vitamin supplementation · Male volunteers aged 40 years or younger; nine matched pairs received vitamins, including hyperhomocysteinemic and normohomocysteinemic subjects
800 mcg8 weeks18
[Treatment of hyperhomocysteinemia and endothelial dysfunction in renal-transplant recipients with vitamin B]
2005 · vitamin treatment (group A) · Stable hyperhomocysteinemic renal-transplant recipients
1 mg26 weeks18
Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial
2016 · Fortified cereal, morning · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness
1.45 mcg12 weeks18
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
2020 · DHA treatment arm · Cognitively unimpaired men and women aged 55 years and older with a first-degree family history of dementia
1 mg26 weeks18
Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial
2016 · Fortified cereal, evening · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness
1.45 mcg12 weeks16
Nutritional status-dependent DNA methylation modifications on adipose tissue in systemic lupus erythematosus women following folic acid and vitamin B12 supplementation: a randomized double-blind placebo-controlled trial
2026 · excess-body-weight intervention group · Women aged 18–45 with inactive systemic lupus erythematosus and excess body weight (BMI ≥25 kg/m²)
2 mcg12 weeks14
Nutritional status-dependent DNA methylation modifications on adipose tissue in systemic lupus erythematosus women following folic acid and vitamin B12 supplementation: a randomized double-blind placebo-controlled trial
2026 · normal-weight intervention group · Women aged 18–45 with inactive systemic lupus erythematosus and normal weight (BMI 18.5–24.9 kg/m²)
2 mcg12 weeks11
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Renal transplant recipients · Renal transplant recipients with hyperhomocysteinemia
400 mcg12 weeks10
Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease
2004 · folic acid combined with vitamin B(12) · Patients with coronary artery disease and at least 70% stenosis of one major coronary artery
250 mcg12 weeks9
Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
1997 · folic acid plus vitamin B12 · Clinically stable renal transplant recipients
400 mcg—7
Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
1997 · vitamin B6, folic acid, and vitamin B12 · Clinically stable renal transplant recipients
400 mcg—7
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Hemodialysis patients receiving folic acid · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients
1 mg12 weeks—
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Hemodialysis patients receiving MTHF · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients
1 mg12 weeks—
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia
2001 · 0 mg folic acid group · Adults with hyper-homocyst(e)inemia receiving hemodialysis for end-stage renal disease
1 mg4 weeks—
Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate
2001 · fenofibrate plus vitamins · men with hyperlipidemia
50 mcg6 weeks—
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
2002 · Folic acid, riboflavin, and vitamin B12 without vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women
400 mcg12 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 1 · Chronic haemodialysis patients; age and sex not specified
429 mcg26 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 2 · Chronic haemodialysis patients; age and sex not specified
429 mcg26 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 3 · Chronic haemodialysis patients; age and sex not specified
429 mcg26 weeks—
Effect of homocysteine reduction by B-vitamin supplementation on markers of clotting activation
2002 · high-dose B-vitamin supplements · Healthy volunteers with homocysteine >16 μmol/L or ≤16 μmol/L
400 mcg8 weeks—
Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease
2002 · folic acid/cobalamin treated group · Patients with coronary artery disease and hyperhomocysteinemia, plasma homocysteine ≥16 micromol/L; age and sex not reported
400 mcg26 weeks—
Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial
2003 · B-vitamin treatment · Community-dwelling apparently healthy adults aged 70–93 years; median age 76 years
500 mcg120 days—
Mineral water fortified with folic acid, vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in men and women
2004 · Fortified mineral water · Free-living men and women without folate deficiency or elevated homocysteine
7.5 mcg8 weeks—
Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial
2004 · Fortified cereal group · Volunteers aged 50–85 years without the listed medical conditions who did not regularly use multiple or B-vitamin supplements or highly fortified breakfast cereal
4.8 mcg12 weeks—
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
2004 · group B · Patients with suspected coronary artery disease; age and sex not stated
400 mcg90 days—
Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia
2004 · group 2 · Patients with metabolic syndrome; age range and sex not reported
500 mcg30 days—
The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction
2004 · B-vitamins · Healthy volunteers, including hyperhomocysteinemic and normohomocysteinemic participants
400 mcg8 weeks—
Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia
2006 · Vitamin group · Community-dwelling men aged 75 years or older
400 mcg2 years—
Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients
2006 · Treatment group · Chronic hemodialysis patients with hyperhomocysteinemia; age and sex not specified
1 mg26 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 1 · Apparently healthy adult volunteers; 50% male; age range not reported
2 mcg6 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 2 · Apparently healthy adult volunteers; 50% male; age range not reported
2 mcg6 weeks—
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
2007 · A: folic acid/vitamin B12/vitamin B6 · Adults aged 38–80 with suspected coronary artery disease
400 mcg26 weeks—
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
2007 · B: folic acid/vitamin B12 · Adults aged 38–80 with suspected coronary artery disease
400 mcg26 weeks—
Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas
2007 · folic acid plus vitamin B-12 · People with a history of colorectal adenoma and MTHFR CC or TT genotype
1.25 mg26 weeks—
Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population
2008 · folate treatment · Chinese renal transplant recipients with hyperhomocysteinemia; age and sex not reported
1 mg26 weeks—
Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients
2008 · group 1 · Adults with diabetes treated with high-dose metformin
400 mcg120 days—
Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy
2008 · oral vitamin treatment · Community-dwelling adults, mean age 76 years
500 mcg120 days—
The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability
2009 · vitamin supplementation · patients diagnosed with migraine with aura; age and sex not reported
400 mcg26 weeks—
Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients
2009 · group II (folic acid and vitamin B12) · Hemodialysis patients; age and sex not reported
1 mg8 weeks—
Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients
2009 · group IV (folic acid and vitamin B12) · Hemodialysis patients; age and sex not reported
1 mg8 weeks—
Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations
2010 · vitamins group · Healthy adults aged 65 years or older with elevated homocysteine (>13 micromol/l)
500 mcg2 years—
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India
2010 · B2 F200 (2 μg vitamin B12 and 200 μg folic acid) · Children and adults from rural families in India; participants included children (mean age 9 years), mothers and fathers, with common vitamin B12 deficiency and elevated homocysteine
2 mcg1 year—
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India
2010 · B10 F200 (10 μg vitamin B12 and 200 μg folic acid) · Children and adults from rural families in India; participants included children (mean age 9 years), mothers and fathers, with common vitamin B12 deficiency and elevated homocysteine
10 mcg1 year—
Community-level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India
2010 · multiple micronutrients (treatment group) · Schoolchildren aged 6–10 years in Himalayan villages of India
1.35 mcg240 days—
Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
2013 · B-vitamin treatment · Elderly adults with mild cognitive impairment and increased dementia risk
500 mcg2 years—
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine
2013 · Folic acid plus vitamin B12 plus vitamin B6 · Adults with suspected or established coronary artery disease who underwent coronary angiography; median age 60 years
400 mcg316 days—
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine
2013 · Folic acid plus vitamin B12 · Adults with suspected or established coronary artery disease who underwent coronary angiography; median age 60 years
400 mcg316 days—
MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial
2018 · Group A: B-vitamins · Adults with a history of cardiovascular disease, including men and women; mean age 61.3 years
20 mcg1716 days—
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
2019 · folic acid + vitamin B12 + vitamin B6 · Adults with suspected coronary artery disease who underwent coronary angiography; mean age about 61 years, 69.8% male
400 mcg165 weeks—
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
2019 · folic acid + vitamin B12 · Adults with suspected coronary artery disease who underwent coronary angiography; mean age about 61 years, 69.8% male
400 mcg165 weeks—
Impact of daily-supervised administration of a package of iron and folic acid and vitamin B(12) on hemoglobin levels among adolescent girls (12-19 years): a cluster randomized control trial
2021 · Experimental group-IFA with vitamin B12 · Adolescent girls aged 12–19 years with mild or moderate anemia
1 mg90 days—
Vitamin requirements for the treatment of hyperhomocysteinemia in humans
1994 · combination of folic acid, vitamin B-12 and vitamin B-6 · men with hyperhomocysteinemia
400 mcg6 weeks—
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
1993 · daily vitamin supplement · Apparently healthy men with moderate hyperhomocysteinemia
400 mcg6 weeks—
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers
1998 · high-dose multivitamin supplements · Patients with a history of recurrent venous thrombosis and hyperhomocysteinemic healthy volunteers
400 mcg——
Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women
1998 · 400 microg folic acid + 6 microg vitamin B-12 · Female volunteers of childbearing age
6 mcg4 weeks—
Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women
1998 · 400 microg folic acid + 400 microg vitamin B-12 · Female volunteers of childbearing age
400 mcg4 weeks—
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
2.6 mcg12 weeks105
Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial
2024 · intervention group · Adults aged 18–70 with obesity and dyslipidemia
1 mg90 days105
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · drink powder · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
5.2 mcg12 weeks93
Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
2021 · test group · Premenopausal Indian women aged 25–45 years in good general health, with BMI 18–30 kg/m²
1 mcg180 days57
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial
2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male
5 mcg60 days52
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD
2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m²
1 mg2 years47
Effects of low-dose B vitamins plus betaine supplementation on lowering homocysteine concentrations among Chinese adults with hyperhomocysteinemia: a randomized, double-blind, controlled preliminary clinical trial
2023 · supplement group · Chinese adults aged 18–65 with hyperhomocysteinemia (blood homocysteine 15–100 μmol/L)
6.4 mcg12 weeks44
Change in Micronutrient Intake among People with Relapsing-Remitting Multiple Sclerosis Adapting the Swank and Wahls Diets: An Analysis of Weighed Food Records
2021 · Wahls (modified Paleolithic elimination diet) group · Adults with relapsing-remitting multiple sclerosis and moderate to severe fatigue; age and sex range not specified
1 mg12 weeks39
Change in Micronutrient Intake among People with Relapsing-Remitting Multiple Sclerosis Adapting the Swank and Wahls Diets: An Analysis of Weighed Food Records
2021 · Swank (low-saturated fat diet) group · Adults with relapsing-remitting multiple sclerosis and moderate to severe fatigue; age and sex range not specified
1 mg12 weeks38
Effect of adding B-vitamins to vitamin D and calcium supplementation on CpG methylation of epigenetic aging markers
2018 · D + Ca + B · Adults, mean age 68.4 years; no specific condition stated
500 mcg1 year32
Plasma trimethylamine-N-oxide following supplementation with vitamin D or D plus B vitamins
2017 · vitamin D + B arm · Participants; age, sex, and health condition not specified
500 mcg1 year25
Metabolic consequences of discretionary fortified beverage consumption containing excessive vitamin B levels in adolescents
2019 · fortified beverage (FB) · Healthy adolescents aged 13–19 years, male and female
500 mcg1 day20
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients
1996 · Supraphysiologic-dose B-vitamin supplementation · Hyperhomocysteinemic dialysis patients
1 mg8 weeks15
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia
2001 · 5 mg folic acid group · Adults with hyper-homocyst(e)inemia receiving hemodialysis for end-stage renal disease
1 mg4 weeks—
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia
2001 · 20 mg folic acid group · Adults with hyper-homocyst(e)inemia receiving hemodialysis for end-stage renal disease
1 mg4 weeks—
Prophylactic iron supplementation in pregnant women in Norway
2001 · 15 mg iron daily · Non-anaemic pregnant women, allocated at about 10 weeks of pregnancy
3 mcg——
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
2002 · Folic acid, riboflavin, and vitamin B12 with vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women
400 mcg12 weeks—
Folate therapy and in-stent restenosis after coronary stenting
2004 · folate group · Patients who had undergone successful coronary stenting
60 mcg26 weeks—
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
2004 · group A · Patients with suspected coronary artery disease; age and sex not stated
400 mcg90 days—
Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins
2005 · All subjects · Adults with chronic kidney disease in MDRD Study A (GFR 25–55 mL/min/1.73 m²) or Study B (GFR 13–24 mL/min/1.73 m²)
6 mcg1 year—
No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease
2006 · B-vitamin group · Patients with symptomatic peripheral arterial occlusive disease and elevated homocysteine levels
50 mcg6 weeks—
One year B and D vitamins supplementation improves metabolic bone markers
2013 · group A · Healthy adults older than 54 years
500 mcg1 year—
Co-administration of methyl donors along with guanidinoacetic acid reduces the incidence of hyperhomocysteinaemia compared with guanidinoacetic acid administration alone
2013 · GAA with methyl donors group · Healthy male and female volunteers
5 mcg8 weeks—
Effects of mixed dietary supplements on total plasma homocysteine concentrations (tHcy): a randomized, double-blind, placebo-controlled trial
2012 · supplement group · hospitalized, acutely ill older patients recovering from acute illness; sex and age range not stated
1.5 mcg6 weeks—
One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation
2017 · group A · Adults older than 54 years; no specific condition stated
500 mcg1 year—
MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial
2018 · Group C: B-vitamins and n-3 fatty acids · Adults with a history of cardiovascular disease, including men and women; mean age 61.3 years
20 mcg1716 days—
Multimicronutrient and omega-3 fatty acid supplementation reduces low-grade inflammation in older participants: An exploratory study
2025 · multimicronutrient and n-3 PUFA supplementation · Healthy, physically active older adults; mean age 75.6 ± 3.9 years; sex not specified
100 mcg12 weeks—
Vitamin B12 Supplementation in Addition to Folic Acid and Iron Improves Hematological and Biochemical Markers in Pregnancy: A Randomized Controlled Trial
2020 · intervention group · Healthy, nonanemic pregnant women; age and sex details beyond pregnancy not reported
5 mcg100 days—
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
2004 · folic acid, vitamin B12, and vitamin B6 group · Patients undergoing coronary angiography
400 mcg1 year—
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
2004 · folic acid and vitamin B12 group · Patients undergoing coronary angiography
400 mcg1 year—
Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment
2006 · Normal MMA group assigned 25 microg cyanocobalamin daily · Elderly people with normal serum MMA
25 mcg90 days—
Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment
2006 · Normal MMA group assigned 100 microg cyanocobalamin daily · Elderly people with normal serum MMA
100 mcg90 days—